Benecchi Christopher has filed 17 insider transactions across 1 company since February 2024.
Most recent transaction: a disposition of 28053 shares of Sage Therapeutics, Inc. ($SAGE) on July 31, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 31, 2025 | Sage Therapeutics, Inc. | $SAGE | Benecchi Christopher | Chief Operating Officer | D | Common Stock | 28053 | $0.00 | 0.0000 | 62,784,397 | 100.00% | 0.04% |
| July 31, 2025 | Sage Therapeutics, Inc. | $SAGE | Benecchi Christopher | Chief Operating Officer | D | Common Stock | 36375 | $0.00 | 0.0000 | 62,784,397 | 100.00% | 0.06% |
| July 31, 2025 | Sage Therapeutics, Inc. | $SAGE | Benecchi Christopher | Chief Operating Officer | D | Stock Option (Right to Buy) | 12500 | $0.00 | 0.0000 | 62,784,397 | 100.00% | 0.02% |
| July 31, 2025 | Sage Therapeutics, Inc. | $SAGE | Benecchi Christopher | Chief Operating Officer | D | Stock Option (Right to Buy) | 40000 | $0.00 | 0.0000 | 62,784,397 | 100.00% | 0.06% |
| April 10, 2025 | Sage Therapeutics, Inc. | $SAGE | Benecchi Christopher | Chief Operating Officer | A | Common Stock | 3255 | $0.00 | 47,170.0000 | 61,480,947 | 7.41% | 0.01% |
| April 10, 2025 | Sage Therapeutics, Inc. | $SAGE | Benecchi Christopher | Chief Operating Officer | F | Common Stock | 793 | $6.91 | 46,377.0000 | 61,480,947 | 1.68% | 0.00% |
| April 10, 2025 | Sage Therapeutics, Inc. | $SAGE | Benecchi Christopher | Chief Operating Officer | A | Common Stock | 2712 | $0.00 | 49,089.0000 | 61,480,947 | 5.85% | 0.00% |
| April 10, 2025 | Sage Therapeutics, Inc. | $SAGE | Benecchi Christopher | Chief Operating Officer | F | Common Stock | 661 | $6.91 | 48,428.0000 | 61,480,947 | 1.35% | 0.00% |
| Feb. 13, 2025 | Sage Therapeutics, Inc. | $SAGE | Benecchi Christopher | Chief Operating Officer | F | Common Stock | 822 | $7.18 | 43,915.0000 | 61,480,947 | 1.84% | 0.00% |
| Jan. 16, 2025 | Sage Therapeutics, Inc. | $SAGE | Benecchi Christopher | Chief Operating Officer | A | Common Stock | 20000 | $0.00 | 44,737.0000 | 0 | 80.85% | 0.00% |
| Jan. 16, 2025 | Sage Therapeutics, Inc. | $SAGE | Benecchi Christopher | Chief Operating Officer | A | Stock Options (Right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 1, 2024 | Sage Therapeutics, Inc. | $SAGE | Benecchi Christopher | Chief Operating Officer | A | Common Stock | 6250 | $0.00 | 24,737.0000 | 0 | 33.81% | 0.00% |
| Nov. 1, 2024 | Sage Therapeutics, Inc. | $SAGE | Benecchi Christopher | Chief Operating Officer | A | Stock Option (Right to buy) | 12500 | $0.00 | 12,500.0000 | 0 | 9999.99% | 0.00% |
| Aug. 5, 2024 | Sage Therapeutics, Inc. | $SAGE | Benecchi Christopher | Chief Business Officer | A | Common Stock | 16200 | $0.00 | 23,242.0000 | 0 | 230.05% | 0.00% |
| Aug. 5, 2024 | Sage Therapeutics, Inc. | $SAGE | Benecchi Christopher | Chief Business Officer | F | Common Stock | 4755 | $8.96 | 18,487.0000 | 0 | 20.46% | 0.00% |
| Feb. 13, 2024 | Sage Therapeutics, Inc. | $SAGE | Benecchi Christopher | Chief Business Officer | A | Common Stock | 13500 | $0.00 | 19,430.0000 | 0 | 227.66% | 0.00% |
| Feb. 13, 2024 | Sage Therapeutics, Inc. | $SAGE | Benecchi Christopher | Chief Business Officer | A | Stock Option (Right to Buy) | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |